How can I differentiate a cardiac thrombus from an atrial myxoma on two‑dimensional echocardiography?

Differentiating Cardiac Thrombus from Atrial Myxoma on 2D Echocardiography

Distinguish thrombus from myxoma by evaluating attachment site, mobility, morphology, and echogenicity—with myxomas typically appearing as mobile, ovoid masses attached to the interatrial septum, while thrombi present as irregular, laminated, non-mobile masses with broad posterior wall attachment in enlarged atria. 1

Key Echocardiographic Features

Myxoma Characteristics

• Attachment site: Typically attached to the interatrial septum (most distinctive feature) 1
• Morphology: Mottled, ovoid, sharply demarcated mass 1
• Mobility: Highly mobile, often prolapsing through valves 1
• Margins: Smooth contours with well-defined borders 2, 3
• Location: Rarely found in the left atrial appendage (LAA) 2

Thrombus Characteristics

• Attachment site: Broad base of attachment to the posterior left atrial wall 1
• Morphology: Irregular, non-mobile, laminated echoes 1
• Mobility: Typically non-mobile or minimally mobile 1
• Atrial size: Usually occurs within an enlarged atrial cavity 1
• Location: Commonly found in the left atrial appendage, especially with atrial fibrillation 2
• Associated findings: Spontaneous echo contrast, atrial fibrillation, mitral stenosis 2

Critical Diagnostic Pitfalls

When Features Overlap

The distinction can be extremely challenging and sometimes impossible on echocardiography alone, as documented in multiple case reports where thrombi mimicked myxomas and vice versa 3, 4, 5, 6, 7. Key overlapping scenarios include:

• Thrombi can appear mobile with smooth contours, mimicking myxoma 3
• Myxomas can occur in atypical locations like the LAA, mimicking thrombus 2
• Both can coexist with mitral stenosis 8
• Organized thrombi may develop well-defined borders resembling tumors 7

Advanced Imaging When Diagnosis Uncertain

Contrast Echocardiography

Contrast echocardiography should be considered when cardiac masses are suspected but not clearly documented or excluded on non-contrast images. 9

• Perfusion assessment: Presence of significant vascularization detected by contrast perfusion protocol establishes cardiac tumor 9
• Limitation: Absence of perfusion does not confirm thrombus, as avascular cardiac tumors are also common 9
• Recommendation strength: Class IIa, Level C for distinguishing tumor from thrombus when CMR unavailable 9

Transesophageal Echocardiography (TEE)

• Superior to transthoracic echo for detailed characterization, especially in mitral stenosis patients 8
• Contrast injection may be considered when native TEE images are inconclusive (Class IIa, Level C) 9

Clinical Decision Algorithm

1. Assess attachment site first: Interatrial septal attachment strongly favors myxoma 1
2. Evaluate mobility: High mobility with prolapse favors myxoma 1
3. Check for clinical context:
   • Atrial fibrillation + LAA location = likely thrombus 2
   • Rheumatic mitral stenosis + posterior wall attachment = likely thrombus 1
4. Consider contrast echocardiography for perfusion assessment if diagnosis remains uncertain 9
5. If still equivocal: Obtain cardiac MRI or proceed with therapeutic anticoagulation trial with repeat imaging 4

Management Implications

When diagnosis remains uncertain despite imaging, a trial of anticoagulation with follow-up echocardiography should be standard of care to avoid unnecessary surgery. 4 Complete resolution of the mass after anticoagulation confirms thrombus diagnosis 4, while persistence or growth suggests tumor requiring surgical excision 4, 5.

The stakes are high: misdiagnosing myxoma as thrombus delays necessary surgery and risks embolization 10, 5, while misdiagnosing thrombus as myxoma leads to unnecessary cardiac surgery 3, 4, 7.